Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 1/2008

01-01-2008

Portal vein thrombosis: CT features

Authors: Hae-Kyung Lee, Seong Jin Park, Bum-Ha Yi, Eun-Kyeong Yeon, Jung Hoon Kim, Hyun-Sook Hong

Published in: Abdominal Radiology | Issue 1/2008

Login to get access

Abstract

There are many causative diseases to produced portal vein thrombosis (PVT) with the most common being liver cirrhosis with hepatocellular carcinoma. Visualization of abnormalities associated with PVT is crucial to diagnosis and appropriate intervention. Dynamic contrast enhanced CT is the best means of diagnosis of PVT and evaluation of various causative diseases. The findings of PVT of the dynamic CT are filling defect partially or totally occluding the vessel lumen and rim enhancement of the vessel wall. Signs and symptoms of PVT may be subtle or nonspecific and overshadowed by the underlying illness. Radiologists should be aware of the clinical situations that predispose a patient to portal or mesenteric vein thrombosis.
Literature
1.
Abbasakoor F, Singhvi R, Robert A, Carr ND (1999) Portal vein embolism J R Soc Med 92:197–198PubMed
2.
Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12:2115–2119PubMed
3.
Valla DC, Condat B (2000) Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32:865–871PubMedCrossRef
4.
Marn CS, Francis IR (1992) CT of portal venous occlusion. AJR 159:717–726PubMed
5.
Gallego C, Velasco M, Marcuello P, Tejedor D, Campo LD, Friera A (2002) Congenictal and acquired anomalies of the portal venous system. RadioGraphics 22:141–159PubMed
6.
Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. Hepatology 40:736–741CrossRef
7.
Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. (1985) Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 89:279–286PubMed
8.
Tublin ME, Dodd GD III, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR 168:719–723PubMed
9.
Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233:379–384PubMedCrossRef
10.
Manzanet G, Sanjuan F, Orbis P, Lopez R, Moya A, Juan M, Vila J, Asensi J, Sendra P, Ruiz J, Prieto M, Mir J (2001) Liver transplantation in patients with portal vein thrombosis. Liver Transpl 7:125–131PubMedCrossRef
11.
Lee KH, Han JK, Jeong JY, Kim YJ, Lee HJ, Park SH, Choi BI (2005) Hepatic attenuation differences associated with obstruction of the portal or hepatic veins in patients with hepatic abscess. AJR 185:1015–1023PubMedCrossRef
12.
Lim HE, Cheong HJ, Woo HJ, Kim WJ, Kim MJ, Lee HC, Park SC (1999) Pylephlebitis associated with appendicitis. Korean J Intern Med 14:73–76PubMed
13.
Lee H, Kim TH, Oh HJ, Kim JI, Park SH, Han JY, Kim JK, Choi KY, Chung IS, Lee SH, Hahn ST (2006) Portal and superior mesenteric venous thrombosis treated with urokinase infusion via superior mesenteric artery. Korean J gastroenterol 48:46–50PubMed
14.
Ozbeck SS, Killi MR, Porbagher MA, Parildar M, Katranci N, Solak A (1999) Portal vein aneurysm. J Ultrasound Med 21:147–151
15.
Fulcher A, Turner M (1997) Aneurysm of the portal vein and superior mesenteric vein. Abdom Imaging 22:289–292CrossRef
Metadata
Title
Portal vein thrombosis: CT features
Authors
Hae-Kyung Lee
Seong Jin Park
Bum-Ha Yi
Eun-Kyeong Yeon
Jung Hoon Kim
Hyun-Sook Hong
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9200-x

Other articles of this Issue 1/2008

Abdominal Radiology 1/2008 Go to the issue

OriginalPaper

The relative roles of magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound in diagnosis of malignant common bile duct strictures: a critically appraised topic

OriginalPaper

Recurrent ovarian granulosa cell tumors: clinical and imaging features

OriginalPaper

Is MRI routinely indicated in pregnant patients with suspected appendicitis after equivocal ultrasound examination?

OriginalPaper

Magnetic resonance enteroclysis compared with conventional enteroclysis and computed tomography enteroclysis: a critically appraised topic

OriginalPaper

Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an “evidence based radiology” review

Erratum

Ureteral fibroepithelial polyp diagnosed preoperatively on virtual CT ureteroscopy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits